최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기소아감염 = Korean journal of pediatric infectious diseases, v.16 no.2, 2009년, pp.183 - 190
김부영 (인하대학교 의과대학 소아과학교실) , 김동현 (질병관리본부) , 이훈재 (인하대학교 의과대학 사회의학교실) , 정수경 (인하대학교 의과대학 사회의학교실) , 이소산 (인하대학교 의과대학 사회의학교실) , 박숙경 (질병관리본부) , 고은영 (질병관리본부) , 홍영진 (인하대학교 의과대학 소아과학교실)
Purpose : To evaluate the number and severity of adverse reactions after Japanese Encephalitis (JE) vaccination in children using different vaccines (inactivated vaccine or live attenuated vaccine) and to determine the ability and safety of the vaccines to provide effective immunization for JE. Meth...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Takahashi H, Pool V, Tsai TF, Chen RT. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine 2000;18:2963-9.
WHO position paper. Japanese encephalitis vaccines. Wkly Epidemiol Rec. 2006;81:331-40.
Kitano T, Oya A. Japanese encephalitis vaccine. In: Researcher's Associates National Institute of Health. Vaccine handbook. Tokyo:Maruzen 1996:103-13.
Korea Center for Disease Control and Prevention. Recent trends in notifiable diseases occurrence based on the data of 2003. Communicable Diseases Monthly Report. 2004;15:135.
Korea Center for Disease Control and Prevention. Japanese encephalitis in Korea since 2001. Public Health Weekly Report 2008;1:289-92.
Halstead SB, Tsai TF. Japanese encephalitis vaccines. In:Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia: WB Saunders 2004:919-58.
Sohn YM. Vaccine adverse reaction and national vaccine injury compensation. J Korean Med Assoc 1997;40: 1635-47.
Liu ZL, Hennessy S, Strom BL, Tsai TF, Wan CM, Tang SC, et al. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2):results of a randomized trial with 26,239 subjects. J Infect Dis 1997;176: 1366-9.
Rottem M, Shoenfeld Y. Vaccination and allergy. Curr Opin Otolaryngol Head Neck Surg 2004;12:223-31.
Sakaguchi M, Nakashima K, Takahashi H, Nakayama T, Fujita H, Inouye S. Anaphylaxis to Japanese encephalitis vaccine. Allergy 2001;56:804-5.
Centers for Disease Control and Prevention. Inactivated Japanese encephalitis virus vaccine. Recommendations of the advisory committee on immunization practices (ACIP). MMWR 1993;42:1-15.
WHO. Global Advisory Committee on vaccine safety, 9-10 June 2005. Wkly Epidemiol Rec 2005;80:242-3.
WHO. Global Advisory Committee on Vaccine Safety, 29-30 November 2006. Wkly Epidemiol Rec 2007;82: 17-24.
WHO. Japanese encephalitis. Wkly Epidemiol Rec 2006; 81:331-40.
WHO Expert committee on Biological Standardization. Guidelines for the production and control of Japanese encephalitis vaccine (live) for human use. WHO Tech Rep Ser 2002;910:1-104.
Global Advisory Committee on Vaccine Safety, 12-13 December 2007. Wkly Epidemiol Rec 2008;83:37-44.
Kohl KS, Gidudu J, Bonhoeffer J, Braun MM, Buettcher M, Chen RT, et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine 2007;25:5671-4.
Beigel J, Kohl KS, Khuri-Bulos N, Bravo L, Nell P, Marcy SM, et al. Rash including mucosal involvement: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007;25:5697-706.
Kohl KS, Walop W, Gidudu J, Ball L, Halperin S, Hammer SJ, et al. Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007; 25:5839-57.
Sejvar JJ, Kohl KS, Bilynsky R, Blumberg D, Cvetkovich T, Galama J, et al. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007;25:5771-92.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.